KPIs & Operating Metrics(New)
Growth Metrics

Abbott Laboratories (ABT) Income from Continuing Operations (2009 - 2026)

Abbott Laboratories recorded quarterly Income from Continuing Operations of 1077000000.0 in Q1 2026, down 39.36% quarter-over-quarter from 1776000000.0 in Q4 2025, and down 18.72% year-over-year from 1325000000.0 in Q1 2025.

Abbott Laboratories' Income from Continuing Operations history runs 18 years deep, the most recent figure standing at 1077000000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations fell 18.72% year-over-year to 1077000000.0; the TTM figure through Mar 2026 stood at 6276000000.0 (down 53.52% YoY), while the FY2025 annual figure was 6524000000.0, down 51.32% from the prior year.
  • Income from Continuing Operations came in at 1077000000.0 for Q1 2026 at Abbott Laboratories, down from 1776000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9229000000.0 in Q4 2024 to a low of 1033000000.0 in Q4 2022.
  • A 5-year average of 1979941176.47 and a median of 1436000000.0 in 2023 frame the typical range for Income from Continuing Operations.
  • Across the five-year window, Income from Continuing Operations surged 478.98% in 2024 and plunged 80.76% in 2025, its largest moves.
  • Abbott Laboratories' Income from Continuing Operations stood at 1033000000.0 in 2022, then surged by 54.31% to 1594000000.0 in 2023, then soared by 478.98% to 9229000000.0 in 2024, then slumped by 80.76% to 1776000000.0 in 2025, then sank by 39.36% to 1077000000.0 in 2026.
  • According to Business Quant data, Income from Continuing Operations over the past three periods registered 1077000000.0, 1776000000.0, and 1644000000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.08 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 745.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.15 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 380.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 273.95 Mn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 199.50 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 411.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 220.30 Mn
10 Zimmer Biomet Holdings 16.17 Bn 15.75 Bn 1.51 Bn 238.30 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.08 Bn
Dec 31, 2025 1.78 Bn
Sep 30, 2025 1.64 Bn
Jun 30, 2025 1.78 Bn
Mar 31, 2025 1.33 Bn
Dec 31, 2024 9.23 Bn
Sep 30, 2024 1.65 Bn
Jun 30, 2024 1.30 Bn
Mar 31, 2024 1.23 Bn
Dec 31, 2023 1.59 Bn
Sep 30, 2023 1.44 Bn
Jun 30, 2023 1.38 Bn
Mar 31, 2023 1.32 Bn
Dec 31, 2022 1.03 Bn
Sep 30, 2022 1.44 Bn
Jun 30, 2022 2.02 Bn
Mar 31, 2022 2.45 Bn
Dec 31, 2021 1.99 Bn
Sep 30, 2021 2.10 Bn
Jun 30, 2021 1.19 Bn
Mar 31, 2021 1.79 Bn
Dec 31, 2020 2.16 Bn
Sep 30, 2020 1.23 Bn
Jun 30, 2020 537.00 Mn
Mar 31, 2020 544.00 Mn
Dec 31, 2019 -331.00 Mn
Sep 30, 2019 960.00 Mn
Jun 30, 2019 1.01 Bn
Mar 31, 2019 672.00 Mn
Dec 31, 2018 1.40 Bn
Sep 30, 2018 552.00 Mn
Jun 30, 2018 718.00 Mn
Mar 31, 2018 409.00 Mn
Dec 31, 2017 -1.75 Bn
Sep 30, 2017 561.00 Mn
Jun 30, 2017 270.00 Mn
Mar 31, 2017 386.00 Mn
Dec 31, 2016 638.00 Mn
Sep 30, 2016 -357.00 Mn
Jun 30, 2016 599.00 Mn
Mar 31, 2016 56.00 Mn
Dec 31, 2015 199.00 Mn
Sep 30, 2015 596.00 Mn
Jun 30, 2015 786.00 Mn
Mar 31, 2015 529.00 Mn
Dec 31, 2014 -1.19 Bn
Sep 30, 2014 438.00 Mn
Jun 30, 2014 425.00 Mn
Mar 31, 2014 224.00 Mn
Dec 31, 2013 51.00 Mn
Sep 30, 2013 644.00 Mn
Jun 30, 2013 476.00 Mn
Mar 31, 2013 544.00 Mn
Dec 31, 2012 -2.22 Bn
Sep 30, 2012 338.92 Mn
Jun 30, 2012 410.84 Mn
Mar 31, 2012 351.22 Mn
Dec 31, 2011 -1.39 Bn
Sep 30, 2011 303.18 Mn
Jun 30, 2011 1.94 Bn
Mar 31, 2011 863.82 Mn
Dec 31, 2010 -5.76 Bn
Sep 30, 2010 890.66 Mn
Jun 30, 2010 1.29 Bn
Mar 31, 2010 1.00 Bn
Dec 31, 2009 2.27 Bn
Sep 30, 2009 1.48 Bn
Jun 30, 2009 1.29 Bn